NRX Pharmaceuticals (NRXP)'s 30-day implied volatility (IV30) was 81.2% at the close on November 11, 2026, down from 88.4% the day before, against a 52-week range of 51.4% to 228.2%. Its 20-day historical volatility was 93.6%.
Data as of November 11, 2026.